Rite Aid Corp. chairman and chief executive officer John Standley has been elected to the CarMax Inc. board of directors. The used car retail chain said late Tuesday that Standley will serve on the audit committee of the board, which now has 12 members. “We are excited to welcome John to the
including mergers and acquisitions, downward pressure on reimbursement rates, consolidation of payers, and a nascent movement to transform pharmacists into providers — now is a good time to take a step back and look at the big picture. What forces will transform the industry, and which
Drug abuse, including misuse of prescription drugs, remains at alarmingly high levels in the U.S. Reports of opioid overdoses and drug-related crimes and car accidents seem to appear in local headlines almost daily.
Teva Pharmaceutical Industries Ltd. has closed its acquisition of the Allergan plc generics business. The companies said Tuesday that under the deal, announced last July, Allergan receives $33.4 billion in cash and 100.3 million shares of Teva stock, valued at $5.
Ateb Inc. plans to integrate pharmacy performance and measurement data from the Pharmacy Quality Solutions (PQS) EQuIPP system into its Patient Management Access Portal (PMAP).
A coalition of pharmacy industry organizations has asked congressional leaders to weigh proposals that would free certain biologic drugs from adherence to U.S. Pharmacopeia (USP) standards.
Pharmacy automation provider Innovation has entered into a technology integration agreement with IMA North America.
Rising PBM and specialty pharmacy sales and recently acquired pharmacy businesses lifted revenue at CVS Health Corp. for the second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. CVS Health said Tuesday that for the second quarter ended June 30, sales climbed 17.
Mylan N.V. this week introduced two new generic drugs in the U.S. market. On Monday, the company announced final Food and Drug Administration approval for dextroamphetamine sulfate extended-release capsules — in dosages of 5 mg, 10 mg and 15 mg — and finasteride tablets 1 mg.
Forrest E. Mars Jr., heir to candy giant Mars Inc. and its former co-president, has died at age 84. Mars Jr., who passed away on July 26, was the eldest son of Audrey and Forrest E. Mars Sr. and the grandson of Frank C. Mars, the founder of Mars Inc. With his brother
Steven Dinh has joined CutisPharma as executive vice president and chief scientific officer. CutisPharma said Monday that Dinh will play a key role at the company, overseeing its efforts to develop its pipeline of drugs for New Drug Application (NDA) submission to the Food and Drug Administration.
Merix Pharmaceutical Corp. has entered into a strategic business alliance with Athens, Greece-based consumer product company Sarantis Group. Terms of the agreement weren’t disclosed.
Walgreens has begun providing bacterial meningitis vaccinations at all of its pharmacies and in-store clinics on a walk-in basis. The drug chain said Monday that the new meningitis B vaccines, Bexsero and Trumenba, protect against most strains of serogroup B meningococcal disease.
On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule interpreting the provisions of the 2010 health care reform law that address the Medicaid Drug Rebate Program (MDRP).
Coty Inc. formed a partnership with Paris-based brand marketing and technology agency BETC to support its Rimmel and Bourjois color cosmetics brands globally. Coty said Monday that the partnership is slated to launch this fall.
Walgreens Boots Alliance executive Adam Pelligrini is leaving the company to join activity tracker device maker Fitbit Inc. as vice president of digital health. Fitbit said Monday that Pellegrini is slated to start at the company on Sept. 6.
